Osmotica Pharmaceuticals plc (OSMT) Prices 6M Share Offering at $5/Sh
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/4/2026
- Wall Street ends sharply higher as Waller remarks ease rate hike fears
- Fed’s Waller open to September rate hold - if disinflation holds up
- Broadcom raises AI chip forecast as Big Tech keeps writing bigger checks
- Nvidia to acquire AI platform Hugging Face in landmark $12.9B deal
- Tesla to unveil Cybercab Texas today, details are few
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Osmotica Announces Pricing of Public Offering of Ordinary Shares
January 8, 2020 8:41 PM ESTBRIDGEWATER, N.J., Jan. 08, 2020 (GLOBE NEWSWIRE) -- Osmotica Pharmaceuticals plc (Nasdaq: OSMT) (Osmotica or the Company), a fully integrated biopharmaceutical company, announced today the pricing of its public offering of 6,000,000 ordinary shares at a price to the public of $5.00 per share. All of the shares will be offered by Osmotica. In addition, Osmotica has granted the underwriters a 30-day option to purchase up to an additional 900,000 ordinary shares at the public offering price less underwriting discounts and commissions. The offering is expected to close on January 13, 2020, subject to customary closing conditions.
